P450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis Affecting All Microsomal P450 Enzymes
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Combined partial deficiency of 17alpha-hydroxylase and 21-hydroxylase activities was first described in 1985; however the genes for P450c17 and P450c21 in these patients lack mutations. In 1986 we postulated that this disorder might be due to mutations in P450 oxidoreductase (POR), the flavoprotein that donates electron to these and all other microsomal P450 enzymes, but this hypothesis was not tested until the POR gene sequence became available through the genome database. We found five POR missense mutations in our first four patients. In vitro assays of the activities of these mutations showed that the standard assay of POR activity, reduction of cytochrome c, correlated poorly with the patients' phenotypes, but that assays of POR-supported 17alpha-hydroxylase and 17,20 lyase activities correlated well. POR deficiency is a new disorder of adrenal and gonadal steroidogenesis that affects all microsomal cytochrome P450 enzymes, hence may have important implications for genetic differences in drug metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationZhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Self-citationArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationHenderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Shen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214
Research works printed but not linked: 20
- Miller W L, 1988, Endocr Rev, 9, 295, 10.1210/edrv-9-3-295 · DOI · Paper page
- Guengerich F P, 2004, Drug Metab Rev, 36, 159, 10.1081/DMR-120033996 · DOI · Paper page
- Wu L, 2003, Genesis, 36, 177, 10.1002/gene.10214 · DOI · Paper page
- Wu L, J Pharmacol Exp Ther
- Miller W L, 1986, N Engl J Med, 314, 1321
- Antley R, 1975, Birth Defects Orig Artic Ser, 11, 397
- Crisponi G, 1997, Clin Dysmorphol, 6, 61, 10.1097/00019605-199701000-00011 · DOI · Paper page
- Reardon W, 1994, Nat Genet, 8, 98, 10.1038/ng0994-98 · DOI · Paper page
- Jabs E W, 1994, Nat Genet, 8, 275, 10.1038/ng1194-275 · DOI · Paper page
- Wilkie A O, 1995, Nat Genet, 9, 165, 10.1038/ng0295-165 · DOI · Paper page
- Rutland P, 1995, Nat Genet, 9, 173, 10.1038/ng0295-173 · DOI · Paper page
- Meyers G A, 1996, Am J Hum Genet, 58, 491
- Schaefer F, 1998, Am J Med Genet, 75, 252, 10.1002/(SICI)1096-8628(19980123)75:3<252::AID-AJMG4>3.0.CO;2-S · DOI · Paper page
- Chun K, 1998, Am J Med Genet, 77, 219, 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K · DOI · Paper page
- Tsai F J, 2001, Acta Paediatr, 90, 595, 10.1111/j.1651-2227.2001.tb00811.x · DOI · Paper page
- Lamb D C, 2001, Biochem Biophys Res Commun, 286, 48, 10.1006/bbrc.2001.5338 · DOI
- 10.1074/jbc.273.6.3158 · DOI · Paper page
- Lu A Y, 1969, J Biol Chem, 244, 3714, 10.1016/S0021-9258(18)83427-5 · DOI · Paper page
- Miller W L, 2004, Trends Endocrinol Metab, 15, 312
- Auchus R J, 1999, Mol Endocrinol, 13, 1169
Cited by
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationModulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Self-citationPharmacogenomics of human P450 oxidoreductase
Pandey, A. V., & Sproll, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00103 · Cited by 92
“…POR mutations in patients and identification several variants of POR in healthy individuals we suggested that POR variants may also impact drug metabolizing P450 enzymes since POR is necessary for activities of all microsomal P450 (Flück et al., 2004, 2007; Pandey et al., 2004; Huang et al., 2005).”
BackgroundInfluentialSelf-citationP450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
Self-citationFlück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
Self-citationUdhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00580 · Cited by 38
Self-citationParween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37
Self-citationBai, Y., Li, J., & Wang, X. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0312-9 · Cited by 34
Rojas Velazquez, M. N., Noebauer, M., & Pandey, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710141 · Cited by 11
“Patients with PORD may develop skeletal deformities resembling Antley-Bixler Syndrome [4, 5, 10-12].”
BackgroundSelf-citationUnal, E., Demiral, M., Yıldırım, R., Taş, F. F., Ceylaner, S., & Özbek, M. N. (2021) · Hormones · doi:10.1007/s42000-020-00249-z · Cited by 12
Wang, C., & Tian, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226387 · Cited by 11
Metadata
- Authors
- Pandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L.
- Venue
- Endocrine Research
- Publisher
- Informa UK Limited
- Published
- 2004-01
- Volume
- 30
- Issue
- 4
- Pages
- 881-888
- ISSN
- 0743-5800 (ISSN-L)
- 1532-4206
- OpenAlex
- W2104596178
- Cited by
- 39
- References
- 20
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.